share_log
Reuters ·  Mar 7 13:00
Arcutis Biotherapeutics Inc - Zoryve Cream 0.15% Shows Favorable Safety and Tolerability in Ad Patients
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 377
Write a comment